LIDOCAINE HYDROCHLORIDE INJECTION

The Defense Logistics Agency awarded a delivery order under contract SPE2DX25D9822 to DMS PHARMACEUTICAL GROUP INC, identified by CAGE code 1UNB0, for the supply of LIDOCAINE HYDROCHLORIDE INJECTION with NSN 6505015332656. The total contract value is $468.60 for ten packages, with delivery required by July 20, 2026, to the address R23182, USS JOHN P MURTHA LPD 26, FPO AP 96694. The contract is structured as a commercial item acquisition under FAR Part 12, incorporating the standard clauses 52.212-1, 52.212-3, 52.212-4, and 52.212-5 by reference, with the awardee certified as a Women-Owned Small Business and eligible under the small business size standard of 1,300 employees. Packaging and marking instructions require all shipments to be labeled with the base contract number SPE2DX-25-D-9822 and the delivery order number SPE2D226F3068, with a directive to ship by the fastest traceable means and prohibit parcel post; however, no formal military packaging or preservation standards such as MIL-STD-129 or MIL-STD-2073 are cited. Inspection and acceptance are to occur at the destination, with the government responsible for final validation of conformance to contract requirements. Payment is to be processed through the Defense Finance and Accounting Service in Columbus, Ohio, using the payment code SL4701 and accounting code BX: 97X4930 5CBX 001 2620 S33189, with invoices submitted to the designated remittance address. Contract administration is managed by the DLA Troop Support office in Philadelphia, with the Contracting Officer listed as Lorinda Ferraiolo and Lisa Quinn serving as the Ordering Officer; no Contracting Officer’s Representative or Technical Representative is explicitly identified. The contract contains no option periods, special security requirements, key personnel designations, or organizational conflict of interest clauses. Submission was through a paper-based process with no electronic portal specified, and while the solicitation originated in March 20